News
Fiction has been preparing us for an unseen, all knowing CEO for decades. Now technology could make it reality.
The newly formed biotech launches with five promising autoimmune candidates, $300 million in funding, and leadership from ...
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 29th: GDS Holdings Limited GDS: This data center operator from China has a Zacks Rank #1 ...
Africa is building a new vaccine future through strategic investments, skilled workforce development, and local manufacturing ...
List today: Mission Produce, Inc. AVO: This fruits producer has seen the Zacks Consensus Estimate for its current year ...
10h
Zacks Investment Research on MSNModerna to Report Q2 Earnings: Is a Beat in Store for the Stock?We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...
Explore more
Eli Lilly's appeal of a decision by the EMA's human medicines committee not to approve its Alzheimer's disease therapy ...
New research by Turkish scientists has found that Pfizer’s Covid-19 vaccine may be associated with subtle changes to the ...
GSK has moved to shore up its R&D pipeline with a strategic-level deal with China's Jiangsu Hengrui Pharma that spans a dozen drug candidates and could be worth up to $12.5 billion.
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics ...
Opinion
1dOpinion
The New Times on MSNFrom scenic views to unexpected talent: My weekend at Lake KivuThis past weekend, I had the joy of escaping the city for a stay at the breathtaking Cleo Hotel, nestled along the shores of Lake Kivu, in western Rwanda. The journey from Kigali to Lake Kivu is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results